{"disease":{"id":"gastric-ulcer","name":"Gastric ulcer","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":21,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"omeprazole","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prilosec","generic_name":"omeprazole","company_name":"AstraZeneca (originally Astra AB)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19","drug_class":"Proton pump inhibitor (PPI)","quality_score":50,"revenue":"1041.0","mechanism":"Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) in gastric parietal cells, potently suppressing stomach acid secretion."},{"drug_id":"dexrabeprazole","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexpure","generic_name":"dexrabeprazole","company_name":"","drug_phase":"unknown","molecular_target":"Proto-oncogene tyrosine-protein kinase receptor Ret","drug_class":"Proton Pump Inhibitors","quality_score":null,"revenue":null,"mechanism":"Dexpure works by irreversibly inhibiting the H+/K+ ATPase enzyme in the stomach lining, reducing acid production."},{"drug_id":"methanthelinium","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Banthine","generic_name":"methanthelinium","company_name":"Takeda","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor","drug_class":"methantheline","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"anisotropine-methylbromide","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valpin","generic_name":"ANISOTROPINE METHYLBROMIDE","company_name":"Endo","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"octatropine methylbromide","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"sofalcone","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SOFALCONE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"sofalcone","quality_score":null,"revenue":null,"mechanism":"SOFALCONE works by inhibiting the production of stomach acid."},{"drug_id":"egualen","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azuloxa","generic_name":"EGUALEN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"ranitidine","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zantac","generic_name":"ranitidine","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Acetylcholinesterase, Histamine H2 receptor","drug_class":"H2 receptor antagonist","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"ranitidine","indication_name":"Maintenance of Healing Gastric Ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zantac","generic_name":"ranitidine","company_name":"GSK (originally Glaxo)","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Acetylcholinesterase, Histamine H2 receptor","drug_class":"H2 receptor antagonist","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"famotidine","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pepcid","generic_name":"famotidine","company_name":"Generic (originally Yamanouchi/Merck)","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2, Solute carrier family 22 member 2","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":56,"revenue":null,"mechanism":"Competitively blocks histamine H2 receptors on gastric parietal cells, reducing basal and stimulated acid secretion."},{"drug_id":"algeldrate","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gaviscon","generic_name":"ALGELDRATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"","drug_class":"algeldrate","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"prevacid","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prevacid","company_name":"Vanderbilt University Medical Center","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 2C19, Cytosolic endo-beta-N-acetylglucosaminidase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"prevacid","indication_name":"NSAID-Induced Gastric Ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Prevacid","company_name":"Vanderbilt University Medical Center","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 2C19, Cytosolic endo-beta-N-acetylglucosaminidase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"esomeprazole","indication_name":"Prevention of NSAID-Induced Gastric Ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nexium","generic_name":"esomeprazole","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"Proton pump inhibitor (PPI)","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"octatropine-methylbromide","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valpin","generic_name":"octatropine methylbromide","company_name":"Endo","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"octatropine methylbromide","quality_score":28,"revenue":null,"mechanism":""},{"drug_id":"revaprazan","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revanex","generic_name":"REVAPRAZAN","company_name":"","drug_phase":"marketed","molecular_target":"Potassium-transporting ATPase","drug_class":"revaprazan","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"aluminum-carbonate","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"aluminum carbonate","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"aluminum carbonate","quality_score":null,"revenue":null,"mechanism":"Aluminum carbonate works by neutralizing stomach acid and forming a protective barrier over the stomach lining."},{"drug_id":"troxipide","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aplace","generic_name":"TROXIPIDE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"troxipide","quality_score":null,"revenue":null,"mechanism":"Troxipide works by inhibiting the enzyme H+/K+ ATPase, which is involved in stomach acid production."},{"drug_id":"cytotec","indication_name":"Prevention of NSAID-Induced Gastric Ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytotec","generic_name":"Misoprostol","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors","drug_class":"NSAID combined with prostaglandin analog","quality_score":70,"revenue":null,"mechanism":"Diclofenac inhibits COX-1/COX-2 to reduce prostaglandins; misoprostol is PGE1 analog protecting gastric mucosa."},{"drug_id":"cimetidine","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tagamet","generic_name":"CIMETIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H2 receptor","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"mepenzolate","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cantil","generic_name":"MEPENZOLATE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M2","drug_class":"Anticholinergic","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"chlorbenzoxamine","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlorobenzoxamin","generic_name":"CHLORBENZOXAMINE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"chlorbenzoxamine","quality_score":null,"revenue":null,"mechanism":"Chlorobenzoxamine works by blocking the action of certain chemicals in the body that contribute to the development of gastric ulcers."},{"drug_id":"nizatidine","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Axid Ar","generic_name":"NIZATIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H2 receptor","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"misoprostol","indication_name":"Prevention of NSAID-Induced Gastric Ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cytotec","generic_name":"misoprostol","company_name":"Generic (originally Searle/Pfizer)","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype, Prostaglandin E2 receptor EP3 subtype, Prostaglandin E2 receptor EP4 subtype","drug_class":"Prostaglandin E1 analog","quality_score":null,"revenue":null,"mechanism":"Synthetic prostaglandin E1 analog that protects gastric mucosa by inhibiting acid secretion and stimulating mucus/bicarbonate, also causes uterine contraction."},{"drug_id":"takecab","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Takecab","company_name":"Genuine Research Center, Egypt","drug_phase":"phase_1","molecular_target":"Potassium-transporting ATPase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"omeprazol","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Omeprazol","company_name":"RenJi Hospital","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lansoprazole","indication_name":"Gastric ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevacid","generic_name":"lansoprazole","company_name":"Generic (originally Takeda)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 2C19, Cytosolic endo-beta-N-acetylglucosaminidase","drug_class":"Proton pump inhibitor (PPI)","quality_score":null,"revenue":null,"mechanism":"Irreversibly inhibits the gastric proton pump to suppress acid secretion."},{"drug_id":"nizatidine","indication_name":"Active Benign Gastric Ulcer Treatment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Axid Ar","generic_name":"NIZATIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H2 receptor","drug_class":"Histamine-2 Receptor Antagonist [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"lansoprazole","indication_name":"NSAID-Induced Gastric Ulcer","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevacid","generic_name":"lansoprazole","company_name":"Generic (originally Takeda)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 2C19, Cytosolic endo-beta-N-acetylglucosaminidase","drug_class":"Proton pump inhibitor (PPI)","quality_score":null,"revenue":null,"mechanism":"Irreversibly inhibits the gastric proton pump to suppress acid secretion."}],"pipeline":[],"offLabel":[],"totalMarketed":28,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07032961","title":"A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05725967","title":"Endoscopic Metabolic and Bariatric Therapies","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Christopher C. Thompson, MD, MSc","has_results":false},{"nct_id":"NCT03214952","title":"Drug Use Surveillance of Vonoprazan for \"Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis\"","phase":"","overall_status":"COMPLETED","enrollment_count":3183,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03228095","title":"Volatiles in Breath and Headspace Analysis - Diagnostic Markers","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"University of Latvia","has_results":false},{"nct_id":"NCT01729182","title":"Nexium Capsules LDA Specific Clinical Experience Investigation","phase":"","overall_status":"COMPLETED","enrollment_count":2363,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01562600","title":"Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation","phase":"","overall_status":"COMPLETED","enrollment_count":1634,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT02423187","title":"Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin","phase":"","overall_status":"COMPLETED","enrollment_count":1568,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT03214198","title":"Special Drug Use Surveillance of Vonoprazan for \"Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use\"","phase":"","overall_status":"COMPLETED","enrollment_count":1304,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03214094","title":"Special Drug Use Surveillance of Vonoprazan for \"Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use\"","phase":"","overall_status":"COMPLETED","enrollment_count":1119,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT05518929","title":"Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1090,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT03972956","title":"Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Renmin Hospital of Wuhan University","has_results":false},{"nct_id":"NCT06168084","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":688,"lead_sponsor_name":"Yongquan Shi","has_results":false},{"nct_id":"NCT03609892","title":"Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":658,"lead_sponsor_name":"Xijing Hospital of Digestive Diseases","has_results":false},{"nct_id":"NCT04678492","title":"Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":658,"lead_sponsor_name":"Xijing Hospital of Digestive Diseases","has_results":false},{"nct_id":"NCT06822413","title":"Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03219723","title":"Drug Use Surveillance of Takecab for \"Supplement to Helicobacter Pylori Eradication\"","phase":"","overall_status":"COMPLETED","enrollment_count":560,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT06167226","title":"Understanding Ayurveda Disease Conditions and Treatment Responses","phase":"","overall_status":"COMPLETED","enrollment_count":497,"lead_sponsor_name":"Ayurai Private Limited","has_results":false},{"nct_id":"NCT06848400","title":"Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios","phase":"NA","overall_status":"RECRUITING","enrollment_count":482,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07068607","title":"Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Yongquan Shi","has_results":false},{"nct_id":"NCT05448001","title":"Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":329,"lead_sponsor_name":"Onconic Therapeutics Inc.","has_results":false},{"nct_id":"NCT03060746","title":"Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects","phase":"","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"DiaSorin Inc.","has_results":false},{"nct_id":"NCT03291418","title":"To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"Antibe Therapeutics Inc.","has_results":false},{"nct_id":"NCT03050307","title":"Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02752698","title":"Domestic Surgical Robot Clinical Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"The Third Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT05656092","title":"A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Hanmi Pharmaceutical Company Limited","has_results":false},{"nct_id":"NCT05742568","title":"Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Xijing Hospital of Digestive Diseases","has_results":false},{"nct_id":"NCT07312370","title":"Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"LanZhou University","has_results":false},{"nct_id":"NCT07123259","title":"Ulcer Pomegranate Muffins","phase":"NA","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"University of Lahore","has_results":false},{"nct_id":"NCT03553563","title":"A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04885751","title":"Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Seoul National University Boramae Hospital","has_results":false},{"nct_id":"NCT06098742","title":"Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Valenta Pharm JSC","has_results":false},{"nct_id":"NCT05320796","title":"The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Prof Urs Zingg","has_results":false},{"nct_id":"NCT06902818","title":"The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Addpharma Inc.","has_results":false},{"nct_id":"NCT07385235","title":"Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Addpharma Inc.","has_results":false},{"nct_id":"NCT04724291","title":"MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"George Washington University","has_results":true},{"nct_id":"NCT05959499","title":"A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of \"BR6002\" and Coadministration of \"BR6002A\" and \"BR6002B\" Under Fed Conditions in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06552624","title":"Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Valenta Pharm JSC","has_results":false},{"nct_id":"NCT05959486","title":"A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of \"BR6002\" and Coadministration of \"BR6002A\" and \"BR6002B\" Under Fasting Conditions in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT02759224","title":"A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT04410211","title":"Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of Malaya","has_results":false},{"nct_id":"NCT05517408","title":"Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06642987","title":"Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT06165237","title":"A Study to Evaluate the Drug-drug Interaction and Safety Between \"BR6001-1\" and \"BR6001-2\"","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT05579444","title":"Systems Biology of Gastrointestinal and Related Diseases","phase":"","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Viome","has_results":false},{"nct_id":"NCT03060733","title":"Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"DiaSorin Inc.","has_results":false}],"total":45},"guidelines":[{"drug_id":"omeprazole","guideline_body":"FDA label","recommendation":"Omeprazole is used to treat gastric ulcers.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}